Blood Marrow Transplant Tandem Meetings

Session : BMT820
Pediatric International Session and Luncheon
Conference : BMT Tandem Meetings
Speaker(s) :
File Size : 11.5 MB

Download Format(s) :
MP3

$15.00

Co-Chairs: Carmen M.S. Bonfim, MD, Federal University of Parana, Curitiba, Brazil; and Richard Kadota, MD, UCSD Moores Cancer Center, La Jolla, CA

Cord Blood Transplantation in Japan - Shunichi Kato, MD, PhD, Tokai University School of Medicine, Tokyo, Japan

Hematopoietic Stem Cell Transplantation for Fanconi's Anemia - Mouhab Ayas, MD, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Pediatric Transplantation in Eastern Europe - Giorgio Dini, MD, G. Gaslini Institute, Genova, Italy

Current Status and Future Trends of Stem Cell Transplantation for Thalassemia in Thailand - Preeda Vanichsetakul, MD, Chulalongkorn University, Bangkok, Thailand

Session : BMT821
Alternative Allogeneic Donor Sources for Transplantation for Childhood Diseases
Conference : BMT Tandem Meetings
Speaker(s) :
File Size : 13.4 MB

Download Format(s) :
MP3

$15.00

Chair: Mitchell S. Cairo, MD, Columbia University, New York, NY

Unrelated Donor Transplants for Pediatric Nonmalignant Disease, including Hemoglobinopathies - Vanderson Rocha, MD, PhD, Eurocord, Hôpital Saint-Louis, Paris, France

Haploidentical Transplants for Childhood Hematologic Malignancies - Gregory A. Hale, MD, St. Jude Children’s Research Hospital, Memphis, TN

The Influence of Cell Dose and HLA Match on Unrelated Cord Blood Transplantation - John E. Wagner, MD, University of Minnesota, Minneapolis, MN

Session : BMT822
Pediatric Perspectives on Immune Reconstitution and Vaccination
Conference : BMT Tandem Meetings
Speaker(s) :
File Size : 15.2 MB

Download Format(s) :
MP3

$15.00

Chair: Paul Szabolcs, MD, Duke University Medical Center, Durham, NC

Improved Immune Reconstitution and Low Mortality after Haploidentical Transplantation Using Reduced-Intensity Conditioning and CD3/CD19 Depletion - Rupert Handgretinger, MD, University of Tuebingen Children's Hospital, Tuebingen, Germany

Immune Reconstitution after Unrelated Cord Blood Transplantation: The Expected and the Unique - Paul Szabolcs, MD, Duke University Medical Center, Durham, NC

Revaccination after Allogeneic Stem Cell Transplantation - Trudy N. Small, MD, Memorial Sloan-Kettering Cancer Center, New York, NY

Session : BMT823
Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency Diseases
Conference : BMT Tandem Meetings
Speaker(s) :
File Size : 16.2 MB

Download Format(s) :
MP3

$15.00

Chair: Morton J. Cowan, MD, UCSF Children’s Hospital, San Francisco, CA

Issues of Transplantation for SCID - Morton J. Cowan, MD, UCSF Children’s Hospital, San Francisco, CA

Late Immunological and Clinical Outcome for a Large Cohort of Transplanted SCID Patients - Bénédicte Neven, MD, Hôpital Necker Enfants Malades, Paris, France

To Ablate or Not To Ablate: That Is the Question (Panel Discussion) - Trudy M. Small, Luigi D. Notarangelo, Naynesh R. Kamani, Neena Kapoor and Alexandra H. Filipovich

Session : BMT824
Late Effects of Transplantation in Children and Adolescents
Conference : BMT Tandem Meetings
Speaker(s) :
File Size : 14.8 MB

Download Format(s) :
MP3

$15.00

Chair: Jean E. Sanders, MD, Fred Hutchinson Cancer Research Center, Seattle, WA

Oral and Dental Late Effects after Pediatric Stem Cell Transplantation - Göran Dahllöf, DDS, PhD, Karolinska Institutet, Huddinge, Sweden

The Kidney after Hematopoietic Cell Transplantation - Sangeeta E. Hingorani, MD, MPH, Children’s Hospital & Regional Medical Center, Seattle, WA

Evaluation for Late Effects after Pediatric Hematopoietic Cell Transplantation - Jean E. Sanders, MD, Fred Hutchinson Cancer Research Center, Seattle, WA

Session : BMT825
PEDIATRIC BEST ABSTRACTS
Conference : BMT Tandem Meetings
Speaker(s) :
File Size : 16.1 MB

Download Format(s) :
MP3

$15.00

Chair: Michael Pulsipher, MD, University of Utah, Salt Lake City, UT

Incidence, Predisposing Factors and Outcome of Engraftment Syndrome in Pediatric Allogeneic Stem Cell Transplant Recipients - Michael Albert, MD (Abstract 65)

Excellent Engraftment and Rapid Immune Recovery in Haploidentical Stem Cell Transplantation Using CD3/CD19 Depleted Peripheral Stem Cell Grafts after Reduced Intensity Conditioning - Peter Bader, PhD (Abstract 66)

Clinical Outcomes of Adolescent Patients Undergoing Hematopoietic Stem Cell Transplant - Christine Duncan, MD (Abstract 67)

Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency: Comparative Results with or without PEG-ADA Withdrawal and Myelosuppressive Chemotherapy - Donald Kohn, MD (Abstract 68)

Sirolimus-Based GVHD Prophylaxis after TBI/TT/Cy Allogeneic HSCT in Pediatric Patients with HR ALL: Results of a Multi-Institutional Pilot Study - Michael Pulsipher, MD (Abstract 69)

Improved Outcome for Transplantation of Pediatric Patients with Non-Malignant Disorders with Unwashed Plasma Depleted Cord Blood - Joseph Rosenthal, MD (Abstract 70)

Session : BMT826
Pediatric Disorders, Histocompatibility and Alternative Stem Cell Sources
Conference : BMT Tandem Meetings
Speaker(s) :
File Size : 10.6 MB

Download Format(s) :
MP3

$15.00

Moderator: Mark R. Litzow, MD, Mayo Clinic College of Medicine, Rochester, MN

Outcomes of Unrelated Umbilical Cord Blood Transplantation in 159 Young Patients with Peroxisomal and Lysosomal Storage Disorders at a Single Center - Vinod Prasad, MD, MRCP (Abstract 63)

Lung Biopsy Has a Significantly Higher Diagnostic Yield Compared to Bronchoalveolar Lavage in Pediatric Hematopoietic Stem Cell Transplant Recipients - Erin Cooney-Qualter, RN (Abstract 64)

Impact of HLA-A Disparities in HSC Transplant from Unrelated Donors - Lee Ann Baxter-Lowe, PhD (Abstract 36)

Cytotoxic T Lymphocytes Specific for Multiple Viruses Can Be Generated from Umbilical Cord Blood for Adoptive Immunotherapy - Catherine M. Bollard, MD (Abstract 37)

Alloanergized HLA-Mismatched Bone Marrow Transplantation – Low Incidence of Clinically Significant GVHD and Viral Infection Resulting in Long Term Disease Free Survival - Jeff Davies, MD (Abstract 38)

Feasibility of Unrelated Umbilical Cord Blood Transplantation in Congenital Childhood Diseases - Caridad Martinez, MD (Abstract 39)

Session : BMT827
Autologous Transplants, Late Effects and Quality of Life
Conference : BMT Tandem Meetings
Speaker(s) :
File Size : 15.3 MB

Download Format(s) :
MP3

$15.00

Moderator: Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center, Seattle, WA

Utility of Co-Morbidity Assessment in Predicting Transplant-Related Toxicity Following Autologous Hematopoietic Transplantation for Multiple Myeloma - David Allan, MD (Abstract 18)

Prospective Neurocognitive Function and Risk Factors at 5 Years after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies, Compared with Controls at 5 Years - Samantha Artherholt, PhD (Abstract 47)

A Simplified Scoring System to Predict Day 100 Non-Relapse Mortality after Hematopoietic Stem Cell Transplantation - Jane Liesveld, MD (Abstract 48)

Rural-Urban Disparities in Survival Outcome after Hematopoietic Stem Cell Transplantation for Hematologic Malignancies - Fausto Loberiza, MD, MS (Abstract 49)

Increased Risk of Cervical Dysplasia in Long Term Survivors of Allogeneic Stem Cell Transplantation – Implications for Screening and HPV Vaccination - Bipin Savani, MD (Abstract 50)

National Institute of Health’s Recommendation for Assessing Lung Function after Allogeneic Hematopoietic Cell Transplantation Predicts Mortality Risk - Eric Walter, MD (Abstract 51)

Session : BMT828
Supportive Care
Conference : BMT Tandem Meetings
Speaker(s) :
File Size : 11.5 MB

Download Format(s) :
MP3

$15.00

Moderator: Jorge Sierra, MD, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Prevention of Late CMV Disease after HCT: A Randomized Double-Blind Multicenter Trial of Valganciclovir Prophylaxis Versus PCR-Guided GCV/VGCV Preemptive Therapy - Michael Boeckh, MD (Abstract 75)

An International Comparison of Current Strategies to Prevent Herpesvirus and Fungal Diseases in HCT Recipients - Judson Heugel, BA (Abstract 76)

Impact of Ribavirin Therapy on Respiratory Syncitial Virus Infection Following Hematopoietic Cell Transplantation - Dhatri Kodali, MD (Abstract 77)

Chronic Hepatitis C, Cirrhosis, and End Stage Liver Disease among 30-Year Survivors of Bone Marrow Transplant - Steven Pergam, MD (Abstract 78)

Pegfilgrastim Appears To Be Equivalent to Multiple Daily Doses of Filgrastim to Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant in Patients with Non-Hodgkin’s Lymphoma: Results of a Randomized Phase II Trial - Robert Rifkin, MD (Abstract 79)

Primary CMV Infection in CMV Seronegative Recipients of a Stem Cell Product from a Seropositive Donor (D+/R-): Frequency of and Risk Factors for Transmission - Ravinder Sandhu, MD (Abstract 80)

Session : BMT829
SATELLITE DINNER SYMPOSIUM: CMV Disease in Stem Cell Transplantation: Challenges and Opportunities
Conference : BMT Tandem Meetings
Speaker(s) :
File Size : 5.2 MB

Download Format(s) :
MP3

$15.00

Chair: Michael J. Boeckh, MD

Managing CMV in Hematopoietic Cell Transplant Recipients - Michael J. Boeckh, MD

CMV Drug Resistance: Clinical Impact and Potential Strategies - Sunwen Chou, MD

Supported by a grant from ViroPharma, Incorporated